{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02078726","recordId":"NCT02078726","peptideSlug":"glucagon","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02078726-glucagon/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02078726.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02078726.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"glucagon","submittedDate":"2014-03-04","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"73f69d43924547345f67c1f812e81e3b54970b95b05d704868063489264ccf08","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-06-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"glucagon","submittedDate":"2015-06-04","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"9f45616744d2584844b1b120a6c036507b178567d4638f77f268a3dd202b82f4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"glucagon","submittedDate":"2016-01-19","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"ab8b48a70b4fd46024e023b764de68974cc8a81e2d2c3d32214afe36d71b1df6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-07-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"glucagon","submittedDate":"2018-07-26","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"04331ed331550c6485101be8f4f96a29ffea0af39bea30943ddff8ce6c9ef770","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-01-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"glucagon","submittedDate":"2019-01-11","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"92b5bdedd1d48ba8b6d1703321d9af9da46b7a5c1eb4aeb2e175a3c625b2821f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Design","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2021-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"glucagon","submittedDate":"2021-03-24","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"0df20df231aa4113ded1556c3322c6dc8e4568bf074ce6a15137ac137405c876","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Baseline Characteristics","Document Section","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"glucagon","submittedDate":"2025-07-01","publishedAt":"2026-08-23","recordId":"NCT02078726","recordSha256":"bd5c19dbad8060affb60cb883d296370710789f4c5dd4d77b753ae286313f309","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02078726?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"9558377421a0303b963040bf4d430601466c898a922a5024940467949be5a1fe"}}